Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Share-based Compensation (2021 - 2026)

Nomad Power Solutions (NMAD) posted Share-based Compensation of $622231.0 for Q2 2026, down 53.69% on a QoQ basis from $1.3 million in Q4 2025, and up 132.18% year-over-year from $267999.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Share-based Compensation (2021 - 2026) Analysis & Trends

Nomad Power Solutions has reported Share-based Compensation for 6 years, with the latest figure at $622231.0 in Q2 2026.

  • On a quarterly basis, Share-based Compensation rose 132.18% year-over-year to $622231.0 in Q2 2026; TTM through Jun 2026 was $2.8 million, a 286.44% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 126.39% from the prior year.
  • Share-based Compensation was $622231.0 for Q2 2026 at Nomad Power Solutions, down from $1.3 million in the prior quarter.
  • The five-year high for Share-based Compensation was $1.3 million in Q4 2025, with the low at -$521734.0 in Q4 2022.
  • Average Share-based Compensation over 5 years is $233019.9, with a median of $190052.5 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation plunged 92.21% in 2024, then surged 1521.08% in 2025.
  • Over 5 years, Share-based Compensation stood at -$521734.0 in 2022, then gained by 12.27% to -$457733.0 in 2023, then surged by 169.48% to $318020.0 in 2024, then surged by 322.49% to $1.3 million in 2025, then tumbled by 53.69% to $622231.0 in 2026.
  • The last three Share-based Compensation figures came in at $622231.0 (Q2 2026), $1.3 million (Q4 2025), and $546499.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 247.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 231.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 108.10 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 243.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 120.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 86.63 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 77.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 83.34 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 622,231.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 622,231.00
Dec 31, 2025 1.34 Mn
Sep 30, 2025 546,499.00
Jun 30, 2025 267,999.00
Mar 31, 2025 99,738.00
Dec 31, 2024 318,020.00
Sep 30, 2024 33,712.00
Jun 30, 2024 33,345.00
Mar 31, 2024 38,819.00
Dec 31, 2023 -457,733.00
Sep 30, 2023 112,106.00
Jun 30, 2023 428,229.00
Mar 31, 2023 42,500.00
Dec 31, 2022 -521,734.00
Sep 30, 2022 396,883.00
Jun 30, 2022 424,094.00
Jun 30, 2021 50,000.00